Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

被引:71
作者
Di Paolo, NC
Tuve, S
Ni, SH
Hellström, KE
Hellström, I
Lieber, A
机构
[1] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[2] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1158/0008-5472.CAN-05-2388
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
dHeat shock proteins such as gp96 have the ability to chaperone peptides and activate antigen-presenting cells. In this study, we tested whether adenovirus-mediated overexpression of secreted or membrane-associated forms of gp96 in tumor cells would stimulate an antitumor immune response. Studies were carried out in C57B1/6 mice bearing aggressively growing s.c. tumors derived from syngeneic TC-1 cells, a cell line that expresses HPV16 E6 and E7 proteins. We found that secreted gp96 can induce protective and therapeutic antitumor immune responses. Our data also indicate that the antitumor effect of sgp96 expression seems to be limited by the induction of suppressive regulatory T cells (Treg). TC-1 tumor transplantation increased the number of splenic and tumor-infiltrating Tregs. Importantly, treatment of mice with low-dose cyclophosphamide decreased the number of Tregs and enhanced the immunostimulatory effect of sgp96 expression. We also tested whether an oncolytic vector (Ad.IR-E1A/TRAIL), that is able to induce tumor cell apoptosis and, potentially, release cryptic tumor epitopes in immunogenic form, could stimulate antitumor immune responses. Although tumor cells infected ex vivo with Ad.IR-E1A/TRAIL had no antitumor effect when used as a vaccine alone, the additional treatment with low-dose cyclophosphamide resulted in the elimination of pre-established tumors. This study gives a rationale for testing approaches that suppress Tregs in combination with oncolytic or immunostimulatory vectors.
引用
收藏
页码:960 / 969
页数:10
相关论文
共 47 条
[1]   HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine [J].
Asea, A ;
Kraeft, SK ;
Kurt-Jones, EA ;
Stevenson, MA ;
Chen, LB ;
Finberg, RW ;
Koo, GC ;
Calderwood, SK .
NATURE MEDICINE, 2000, 6 (04) :435-442
[2]   Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells [J].
Barker, RN ;
Erwig, LP ;
Hill, KSK ;
Devine, A ;
Pearce, WP ;
Rees, AJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (02) :220-225
[3]   A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication [J].
Bernt, K ;
Liang, M ;
Ye, X ;
Ni, SH ;
Li, ZY ;
Ye, SL ;
Hu, F ;
Lieber, A .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10994-11002
[4]  
BERNT K, 2005, CANC RSE, V10, P4343
[5]   Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine [J].
Beyer, M ;
Kochanek, M ;
Darabi, K ;
Popov, A ;
Jensen, M ;
Endl, E ;
Knolle, PA ;
Thomas, RK ;
von Bergwelt-Baildon, M ;
Bebey, S ;
Hallek, M ;
Schultze, JL .
BLOOD, 2005, 106 (06) :2018-2025
[6]  
Carlson CA, 2002, METHOD ENZYMOL, V346, P277
[7]   The dual nature of specific immunological activity of tumor-derived gp96 preparations [J].
Chandawarkar, RY ;
Wagh, MS ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (09) :1437-1442
[8]  
COURREGES MC, 2005, CANC GENE THER
[9]   Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of proteases [J].
Fadok, VA ;
Bratton, DL ;
Guthrie, L ;
Henson, PM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (11) :6847-6854
[10]   VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS [J].
FELTKAMP, MCW ;
SMITS, HL ;
VIERBOOM, MPM ;
MINNAAR, RP ;
DEJONGH, BM ;
DRIJFHOUT, JW ;
TERSCHEGGET, J ;
MELIEF, CJM ;
KAST, WM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2242-2249